Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Corticosteroids vs Surgery in Pediatric OSA
NCT06917768Completed
- Sponsor
- Hôtel-Dieu de France
- Start
- Dec 2022
- Primary completion
- Dec 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Open-label trial of prednisolone in obstructive sleep apnea (OSA) (2 arms), sponsored by Hôtel-Dieu de France. Primary endpoint: Effectiveness of low-dose, short-term oral corticosteroids in the treatment of OSA in children at 6 months. Started Dec 2022; status: completed.
02
Drugs
prednisolone
03
Conditions
obstructive sleep apnea (OSA)
Beyond the preview
Go deeper on NCT06917768.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06917768.